Pleiotropic effects of simvastatin in physically trained ovariectomized rats. 2013

N Bernardes, and J O Brito, and T G Fernandes, and S F Llesuy, and M C Irigoyen, and A Belló-Klein, and K De Angelis
Universidade Nove de Julho-UNINOVE, São Paulo, SP, Brasil.

This study tested the hypothesis that simvastatin treatment can improve cardiovascular and autonomic functions and membrane lipoperoxidation, with an increased effect when applied to physically trained ovariectomized rats. Ovariectomized rats were divided into sedentary, sedentary+simvastatin and trained+simvastatin groups (n = 8 each). Exercise training was performed on a treadmill for 8 weeks and simvastatin (5 mg/kg) was administered in the last 2 weeks. Blood pressure (BP) was recorded in conscious animals. Baroreflex sensitivity was evaluated by the tachycardic and bradycardic responses to BP changes. Cardiac vagal and sympathetic effects were determined using methylatropine and propranolol. Oxidative stress was evaluated based on heart and liver lipoperoxidation using the chemiluminescence method. The simvastatin-treated groups presented reduced body weight and mean BP (trained+simvastatin = 99 ± 2 and sedentary+simvastatin = 107 ± 2 mmHg) compared to the sedentary group (122 ± 1 mmHg). Furthermore, the trained group showed lower BP and heart rate compared to the other groups. Tachycardic and bradycardic responses were enhanced in both simvastatin-treated groups. The vagal effect was increased in the trained+simvastatin group and the sympathetic effect was decreased in the sedentary+simvastatin group. Hepatic lipoperoxidation was reduced in sedentary+simvastatin (≈21%) and trained+simvastatin groups (≈57%) compared to the sedentary group. Correlation analysis involving all animals demonstrated that cardiac lipoperoxidation was negatively related to the vagal effect (r = -0.7) and positively correlated to the sympathetic effect (r = 0.7). In conclusion, improvement in cardiovascular and autonomic functions associated with a reduction of lipoperoxidation with simvastatin treatment was increased in trained ovariectomized rats.

UI MeSH Term Description Entries
D010052 Ovariectomy The surgical removal of one or both ovaries. Castration, Female,Oophorectomy,Bilateral Ovariectomy,Bilateral Ovariectomies,Castrations, Female,Female Castration,Female Castrations,Oophorectomies,Ovariectomies,Ovariectomies, Bilateral,Ovariectomy, Bilateral
D010805 Physical Conditioning, Animal Diet modification and physical exercise to improve the ability of animals to perform physical activities. Animal Physical Conditioning,Animal Physical Conditionings,Conditioning, Animal Physical,Conditionings, Animal Physical,Physical Conditionings, Animal
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D005260 Female Females
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000960 Hypolipidemic Agents Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS. Antihyperlipidemic,Antilipemic,Antilipemic Agents,Antilipemic Drug,Hypolipidemic Agent,Hypolipidemic Drug,Antihyperlipemics,Antihyperlipidemics,Antilipemic Drugs,Antilipemics,Hypolipidemic Drugs,Agent, Hypolipidemic,Agents, Antilipemic,Agents, Hypolipidemic,Drug, Antilipemic,Drug, Hypolipidemic,Drugs, Antilipemic,Drugs, Hypolipidemic
D001341 Autonomic Nervous System The ENTERIC NERVOUS SYSTEM; PARASYMPATHETIC NERVOUS SYSTEM; and SYMPATHETIC NERVOUS SYSTEM taken together. Generally speaking, the autonomic nervous system regulates the internal environment during both peaceful activity and physical or emotional stress. Autonomic activity is controlled and integrated by the CENTRAL NERVOUS SYSTEM, especially the HYPOTHALAMUS and the SOLITARY NUCLEUS, which receive information relayed from VISCERAL AFFERENTS. Vegetative Nervous System,Visceral Nervous System,Autonomic Nervous Systems,Nervous System, Autonomic,Nervous System, Vegetative,Nervous System, Visceral,Nervous Systems, Autonomic,Nervous Systems, Vegetative,Nervous Systems, Visceral,System, Autonomic Nervous,System, Vegetative Nervous,System, Visceral Nervous,Systems, Autonomic Nervous,Systems, Vegetative Nervous,Systems, Visceral Nervous,Vegetative Nervous Systems,Visceral Nervous Systems
D015227 Lipid Peroxidation Peroxidase catalyzed oxidation of lipids using hydrogen peroxide as an electron acceptor. Lipid Peroxidations,Peroxidation, Lipid,Peroxidations, Lipid
D017704 Baroreflex A response by the BARORECEPTORS to increased BLOOD PRESSURE. Increased pressure stretches BLOOD VESSELS which activates the baroreceptors in the vessel walls. The net response of the CENTRAL NERVOUS SYSTEM is a reduction of central sympathetic outflow. This reduces blood pressure both by decreasing peripheral VASCULAR RESISTANCE and by lowering CARDIAC OUTPUT. Because the baroreceptors are tonically active, the baroreflex can compensate rapidly for both increases and decreases in blood pressure. Reflex, Baroreceptor,Baroreceptor Reflex,Baroreceptor Reflexes,Baroreflexes,Reflexes, Baroreceptor

Related Publications

N Bernardes, and J O Brito, and T G Fernandes, and S F Llesuy, and M C Irigoyen, and A Belló-Klein, and K De Angelis
January 2016, American journal of therapeutics,
N Bernardes, and J O Brito, and T G Fernandes, and S F Llesuy, and M C Irigoyen, and A Belló-Klein, and K De Angelis
July 2012, International journal of cardiology,
N Bernardes, and J O Brito, and T G Fernandes, and S F Llesuy, and M C Irigoyen, and A Belló-Klein, and K De Angelis
March 1978, Cardiovascular research,
N Bernardes, and J O Brito, and T G Fernandes, and S F Llesuy, and M C Irigoyen, and A Belló-Klein, and K De Angelis
March 1981, Metabolism: clinical and experimental,
N Bernardes, and J O Brito, and T G Fernandes, and S F Llesuy, and M C Irigoyen, and A Belló-Klein, and K De Angelis
March 2010, Nutrition (Burbank, Los Angeles County, Calif.),
N Bernardes, and J O Brito, and T G Fernandes, and S F Llesuy, and M C Irigoyen, and A Belló-Klein, and K De Angelis
April 2009, European journal of clinical investigation,
N Bernardes, and J O Brito, and T G Fernandes, and S F Llesuy, and M C Irigoyen, and A Belló-Klein, and K De Angelis
June 2012, European review for medical and pharmacological sciences,
N Bernardes, and J O Brito, and T G Fernandes, and S F Llesuy, and M C Irigoyen, and A Belló-Klein, and K De Angelis
May 1994, Cellular and molecular biology (Noisy-le-Grand, France),
N Bernardes, and J O Brito, and T G Fernandes, and S F Llesuy, and M C Irigoyen, and A Belló-Klein, and K De Angelis
February 2016, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
N Bernardes, and J O Brito, and T G Fernandes, and S F Llesuy, and M C Irigoyen, and A Belló-Klein, and K De Angelis
December 2009, Endocrinology,
Copied contents to your clipboard!